NCT03578003

Brief Summary

One of the principal complicating factors associated with traumatic brain injury (TBI) is sleep-wake disturbances (e.g., insomnia, excessive daytime sleepiness, and circadian rhythm sleep disorders). Morning bright light therapy (MBLT) has been shown to improve sleep quality in a variety of conditions, but little has been done investigating the utility of MBLT in improving sleep in Veterans with TBI. This proposal aims to determine the effect of MBLT on sleep quality in Veterans with TBI. Veterans with and without TBI will be recruited from the VA Portland Health Care System. Baseline questionnaires and 7 days of actigraphy will be collected prior to engaging in 60 minutes of MBLT daily for 4 weeks, during which actigraphy will also be collected continuously. Post-MBLT questionnaire data will be collected, and follow-up questionnaire data will be collected at 3 months post-MBLT.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Aug 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Aug 2017Dec 2026

Study Start

First participant enrolled

August 2, 2017

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

June 13, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 5, 2018

Completed
8.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

November 14, 2025

Status Verified

November 1, 2025

Enrollment Period

9.3 years

First QC Date

June 13, 2018

Last Update Submit

November 12, 2025

Conditions

Keywords

SleepBright Light

Outcome Measures

Primary Outcomes (1)

  • Change in Insomnia Severity Index (ISI)

    Measures self-reported insomnia severity; total score range = 0-28 (higher total score = worse insomnia)

    Baseline; after 4 weeks of intervention; and 2 months after the end of intervention

Study Arms (2)

Morning Bright Light Therapy

EXPERIMENTAL

Subjects who engage in morning bight light therapy

Other: Morning Bright Light Therapy

Control

NO INTERVENTION

Subjects who do not engage in morning bright light therapy

Interventions

60 minutes of bright light therapy (10,000 lux) received within 90 minutes of waking

Morning Bright Light Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veterans

You may not qualify if:

  • History of bipolar disorder
  • History of macular degeneration
  • Non-English speaking
  • Decisionally impaired
  • Currently using a light box

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Portland Health Care System

Portand, Oregon, 97239, United States

RECRUITING

Related Publications (1)

  • Elliott JE, McBride AA, Balba NM, Thomas SV, Pattinson CL, Morasco BJ, Wilkerson A, Gill JM, Lim MM. Feasibility and preliminary efficacy for morning bright light therapy to improve sleep and plasma biomarkers in US Veterans with TBI. A prospective, open-label, single-arm trial. PLoS One. 2022 Apr 14;17(4):e0262955. doi: 10.1371/journal.pone.0262955. eCollection 2022.

MeSH Terms

Conditions

Brain Injuries, TraumaticStress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesStress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Miranda M Lim, MD, PhD

    Portland VA Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Miranda M Lim, MD, PhD

CONTACT

Jonathan E Elliott, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Physician and Assistant Professor

Study Record Dates

First Submitted

June 13, 2018

First Posted

July 5, 2018

Study Start

August 2, 2017

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

November 14, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

All non-identifiable data will be made available to qualified researchers on request to the study PI.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Information will be sent as soon as is practical and will be available as long as the PI is available.
Access Criteria
Legitimate research agenda, including but not limited to request to double-check presented or published results and novel analyses.

Locations